You have 9 free searches left this month | to do more

LY3502970

LY3502970 is a drug used to treat Healthy, Diabetes Mellitus, Type 2, Obesity, and other conditions. LY3502970 is being actively studied in 5 studies and prior, has been studied in 3.

Top SponsorsTop SitesTop Investigators
Eli Lilly and CompanyAnaheim Clinical Trials, LLC
Bugat Pal Korhaz
Capital Area Research, LLC
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
Recruiting
  • Healthy
  • LY3502970
  • Singapore, Singapore
    Lilly Centre for Clinical Pharmacology
2021-11-17
Nov 17, 2021
E
Recruiting
  • Healthy
  • Nottingham, United Kingdom
    Quotient Clinical Ltd
2021-12-20
Dec 20, 2021
E
Completed
  • Healthy
  • LY3502970
  • +4 more
  • Dallas, Texas
    Covance Dallas
2020-11-17
Nov 17, 2020
E
Completed
  • Healthy
  • Leeds, United Kingdom
    Covance Clinical Research
2021-07-16
Jul 16, 2021
E
Completed
  • Diabetes Mellitus, Type 2
  • LY3502970
  • Placebo
  • Hialeah, Florida
  • +5 more
2021-07-26
Jul 26, 2021
E
Recruiting
  • Diabetes Mellitus, Type 2
  • LY3502970
  • Placebo
  • Osaka-shi, Osaka, Japan
  • +4 more
2021-12-16
Dec 16, 2021
E
Recruiting
  • Obesity
  • Overweight and Obesity
  • LY3502970
  • Placebo
  • Anaheim, California
  • +35 more
2022-01-05
Jan 5, 2022
E
Recruiting
  • Type 2 Diabetes
  • LY3502970
  • +2 more
  • Anaheim, California
  • +44 more
2022-01-05
Jan 5, 2022